Accessibility Menu
 
Odonate logo

Odonate

(OTC) ODT

Current PriceN/A
Market CapN/A
Since IPO (2017)-92%
5 Year-95%
1 Year+17%
1 Month+10%

Odonate Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$102.07M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Odonate

Industry

Pharmaceuticals

CEO

Kevin C. Tang

Headquarters

San Diego, CA 10016, US

ODT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

7%

Return on Capital

-1%

Return on Assets

7%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$127.43M

EBITDA

$126.99M

Operating Cash Flow

$113.13M

Capital Expenditure

$432.00K

Free Cash Flow

$113.56M

Cash & ST Invst.

$157.26M

Total Debt

$5.33M

Odonate Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

137

N/A

Net Income

$14.00M

+54.1%

EBITDA

$13.88M

+54.5%

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Net Cash

$90.18M

-50.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.11M

N/A

Short Term Debt

$744.00K

N/A

Return on Assets

6.63%

N/A

Return on Invested Capital

-0.74%

N/A

Free Cash Flow

$15.10M

+40.4%

Operating Cash Flow

$15.10M

+40.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MGTAMagenta Therapeutics, Inc.
$0.70-7.74%
RENBLunai Bioworks Inc.
$1.42+0.00%
GRNAGreenLight Biosciences Holdings
$0.30-0.03%
PSTIPluristem Therapeutics Inc.
$1.00-2.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.02%

Questions About ODT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.